CRBP

13.14

0.23% -0.03

Handel nachbörslich: 12.89 -0.25 -1.90%

Corbus Pharmaceuticals Holdings Inc (CRBP)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$13.17

Offen:

$13.05

24-Stunden-Volumen:

242.79K

Relative Volume:

0.55

Marktkapitalisierung:

$156.26M

Einnahmen:

$1.54M

Nettoeinkommen (Verlust:

$-38.70M

KGV:

-1.1945

EPS:

-11

Netto-Cashflow:

$-36.86M

1W Leistung:

-1.43%

1M Leistung:

-26.92%

6M Leistung:

-69.79%

1J Leistung:

+143.33%

1-Tages-Spanne:

$12.79

$13.34

1-Wochen-Bereich:

$12.64

$13.46

52-Wochen-Spanne:

$5.30

$61.90

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Firmenname

Corbus Pharmaceuticals Holdings Inc

Sektor

Healthcare (1198)

Branche

Biotechnology (668)

Telefon

617-963-0103

Adresse

500 RIVER RIDGE DRIVE, NORWOOD, MA

Mitarbeiter

Twitter

@corbuspharma

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

CRBP's Discussions on Twitter

Vergleichen Sie CRBP mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CRBP Corbus Pharmaceuticals Holdings Inc	13.14	156.26M	1.54M	-38.70M	-36.86M	-4.67
VRTX Vertex Pharmaceuticals Inc	410.65	105.21B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	716.68	78.48B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	632.04	37.55B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	242.50	31.19B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.77	27.43B	3.30B	-501.07M	1.03B	-2.1146

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-02	Eingeleitet	Piper Sandler	Overweight
2024-07-30	Eingeleitet	Wedbush	Outperform
2024-07-22	Fortgesetzt	H.C. Wainwright	Buy
2024-06-26	Eingeleitet	B. Riley Securities	Buy
2024-06-03	Bestätigt	Oppenheimer	Outperform
2024-05-13	Eingeleitet	RBC Capital Mkts	Outperform
2024-03-06	Hochstufung	Jefferies	Hold → Buy
2020-09-08	Herabstufung	BTIG Research	Buy → Neutral
2020-09-08	Herabstufung	Jefferies	Buy → Hold
2020-09-08	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2020-09-08	Herabstufung	ROTH Capital	Buy → Neutral
2020-07-07	Eingeleitet	ROTH Capital	Buy
2020-06-17	Eingeleitet	BTIG Research	Buy
2020-03-26	Eingeleitet	Nomura	Buy
2019-04-05	Eingeleitet	Jefferies	Buy
2019-03-20	Eingeleitet	Oppenheimer	Outperform
2019-01-11	Bestätigt	Cantor Fitzgerald	Overweight
2018-12-26	Eingeleitet	H.C. Wainwright	Buy
2018-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2018-10-24	Eingeleitet	B. Riley FBR	Buy
2018-01-19	Eingeleitet	Raymond James	Outperform
2017-12-14	Bestätigt	Cantor Fitzgerald	Overweight
2017-11-08	Bestätigt	Noble Financial	Buy
2017-09-29	Fortgesetzt	Noble Financial	Buy
2017-03-30	Bestätigt	Cantor Fitzgerald	Overweight
2016-11-15	Bestätigt	JMP Securities	Mkt Outperform
2016-11-11	Bestätigt	Noble Financial	Buy

Alle ansehen

Corbus Pharmaceuticals Holdings Inc Aktie (CRBP) Neueste Nachrichten

05:38 AM

State Street Corp Buys 153,243 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

05:38 AM

Dec 24, 2024

Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch

Dec 24, 2024

Dec 22, 2024

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Stock Holdings Boosted by Fmr LLC - Defense World

Dec 22, 2024

Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Target Price at $62.00 - Defense World

Dec 22, 2024

Dec 19, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Dec 19, 2024

Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) PT at $62.00 - MarketBeat

Dec 19, 2024

Dec 18, 2024

(CRBP) Investment Report - Stock Traders Daily

Dec 18, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Dec 18, 2024

Dec 17, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Dec 17, 2024

Mizuho remains bullish on Corbus stock, sees encouraging outlook for Nectin-4 ADC - Investing.com Canada

Dec 17, 2024

Charles Schwab Investment Management Inc. Buys 64,800 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - MarketBeat

Dec 17, 2024

Charles Schwab Investment Management Inc. Boosts Stock Position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Dec 17, 2024

Dec 16, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

Dec 16, 2024

Corbus Pharmaceuticals' SWOT analysis: stock's potential in cancer and obesity - Investing.com

Dec 16, 2024

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Bought by The Manufacturers Life Insurance Company - Defense World

Dec 16, 2024

Dec 13, 2024

Corbus Pharmaceuticals Holdings Inc. stock remains steady Friday, underperforms market - MarketWatch

Dec 13, 2024

Dec 12, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Dec 12, 2024

Dec 10, 2024

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Dec 10, 2024

Corbus begins phase 1 trial for advanced solid tumors By Investing.com - Investing.com South Africa

Dec 10, 2024

Dec 09, 2024

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

Dec 09, 2024

Corbus begins phase 1 trial for advanced solid tumors - Investing.com

Dec 09, 2024

Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors - The Manila Times

Dec 09, 2024

Corbus Pharmaceuticals Announces Dosing of First Patient in - GlobeNewswire

Dec 09, 2024

Corbus Pharma Launches Phase 1 Trial for Novel Cancer Immunotherapy CRB-601 - StockTitan

Dec 09, 2024

Dec 08, 2024

Walleye Capital LLC Sells 113,428 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - MarketBeat

Dec 08, 2024

Dec 04, 2024

Why Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Insider Monkey

Dec 04, 2024

FDA fast tracks Corbus drug for cervical cancer treatment By Investing.com - Investing.com Canada

Dec 04, 2024

Corbus Pharmaceuticals' CRB-701 Receives FDA Fast Track Designation for Metastatic Cervical Cancer Treatment - Marketscreener.com

Dec 04, 2024

Dec 03, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Dec 03, 2024

Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow

Dec 03, 2024

Piper Sandler Initiates Coverage of Corbus Pharmaceuticals Holdings (CRBP) with Overweight Recommendation - MSN

Dec 03, 2024

HighVista Strategies LLC Acquires 36,499 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - MarketBeat

Dec 03, 2024

FDA fast tracks Corbus drug for cervical cancer treatment - Investing.com

Dec 03, 2024

FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer - GlobeNewswire

Dec 03, 2024

Corbus Pharma Secures FDA Fast Track Status for Cancer Drug CRB-701 - StockTitan

Dec 03, 2024

Dec 02, 2024

Corbus, Viking initiated at overweight by Piper Sandler - MSN

Dec 02, 2024

CRBP (Corbus Pharmaceuticals Holdings) Financial Strength : 8 (As of Sep. 2024) - GuruFocus.com

Dec 02, 2024

Corbus Pharmaceuticals stock rated Overweight, CRB-701 could drive solid tumor efficacy - Investing.com Canada

Dec 02, 2024

Corbus Pharmaceuticals Holdings Inc. stock rises Monday, still underperforms market - MarketWatch

Dec 02, 2024

Corbus, Viking initiated at overweight by Piper Sandler (NASDAQ:VKTX) - Seeking Alpha

Dec 02, 2024

CRBP (Corbus Pharmaceuticals Holdings) Enterprise Value : $61.43 Mil (As of Dec. 02, 2024) - GuruFocus.com

Dec 02, 2024

Nov 30, 2024

Victory Capital Management Inc. Boosts Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Nov 30, 2024

Nov 28, 2024

Acuta Capital Partners LLC Reduces Stock Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - MarketBeat

Nov 28, 2024

Nov 26, 2024